Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Pifithrin-β hydrobromide (Cyclic PFT-α) is an inhibitor of p53; reversibly blocks p53-dependent transcriptional activation and apoptosis. Protects against neuronal death in models of stroke and neurodegenerative disorders. Active in vivo; protects mice from the side-effects of Y therapy associated with p53 induction. Supresses self-renewal of embryonic stem cells. Also aryl hydrocarbon receptor (AHR) agonist, causes upregulation of AHR target gene CYP1A1 (EC50 = 1.1 μM).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | In stock | $ 34.00 | |
5 mg | In stock | $ 51.00 | |
10 mg | In stock | $ 85.00 | |
25 mg | In stock | $ 153.00 | |
50 mg | In stock | $ 223.00 | |
100 mg | In stock | $ 332.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 53.00 |
Description | Pifithrin-β hydrobromide (Cyclic PFT-α) is an inhibitor of p53; reversibly blocks p53-dependent transcriptional activation and apoptosis. Protects against neuronal death in models of stroke and neurodegenerative disorders. Active in vivo; protects mice from the side-effects of Y therapy associated with p53 induction. Supresses self-renewal of embryonic stem cells. Also aryl hydrocarbon receptor (AHR) agonist, causes upregulation of AHR target gene CYP1A1 (EC50 = 1.1 μM). |
Targets&IC50 | p53:23 μM(EC50) |
In vitro | PFTα molecule could not take a planar conformation required for AhR activation whereas PFTβ showed a conformation similar to those of the prototypical AhR ligand β-naphthoflavone. In both cell lines, PFTα and PFTβ provoked different responses related with AhR activation. However, when cyclization of PFTα to PFTβ was hampered by acetylation of the exocyclic nitrogen, all these responses were not observed. These results lead to the conclusion that the activation of the AhR is probably caused by PFTβ instead of PFTα. |
Synonyms | Cyclic PFT-α, PFT-β, Cyclic Pifithrin-α hydrobromide, Pifithrin-β, PFT β (hydrobromide) |
Molecular Weight | 349.29 |
Formula | C16H17BrN2S |
CAS No. | 511296-88-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 13.75 mg/mL (39.37 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Pifithrin-β hydrobromide 511296-88-1 Apoptosis p53 Ferroptosis Cyclic PFT-α inhibit PFT-beta Pifithrin-b PFT β Cyclic PFT-a PFT-β MDM-2/p53 PFT-b PFT beta Pifithrinβ hydrobromide Cyclic Pifithrin-a Hydrobromide PFT b Cyclic Pifithrin-α Hydrobromide Pifithrin-b Hydrobromide Pifithrin β hydrobromide Cyclic Pifithrin-α hydrobromide Pifithrin-beta Cyclic Pifithrin-α Inhibitor Pifithrin-β Cyclic Pifithrin-alpha Hydrobromide Cyclic PFT-alpha Pifithrin-beta Hydrobromide PFT β (hydrobromide) Pifithrin-β Hydrobromide inhibitor